|
Q1 FY2027
As of Jun 30, 2026
|
Q4 FY2026
As of Mar 31, 2026
|
Q3 FY2026
As of Dec 31, 2025
|
Q2 FY2026
As of Sep 30, 2025
|
Q1 FY2026
As of Jun 30, 2025
|
Q4 FY2025
As of Mar 31, 2025
|
Q3 FY2025
As of Dec 31, 2024
|
Q2 FY2025
As of Sep 30, 2024
|
Q1 FY2025
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash and due from banks | |||||||||
| Interest-bearing deposits in other financial institutions | |||||||||
| Federal funds sold | |||||||||
| Cash and cash equivalents | |||||||||
| Available-for-sale securities | |||||||||
| Loans receivable | |||||||||
| Allowance for credit losses | |||||||||
| Net loans | |||||||||
| Premises and equipment | |||||||||
| Restricted stock | |||||||||
| Bank owned life insurance | |||||||||
| Accrued interest receivable | |||||||||
| Net deferred federal income taxes | |||||||||
| Other assets | |||||||||
| Total assets | |||||||||
| Liabilities and Stockholders' Equity | |||||||||
| Liabilities | |||||||||
| Deposits | |||||||||
| Demand | |||||||||
| Savings and money market | |||||||||
| Time | |||||||||
| Total deposits | |||||||||
| Advances from the Federal Home Loan Bank | |||||||||
| Stock subscription proceeds in escrow | |||||||||
| Advances by borrowers for taxes and insurance | |||||||||
| Directors plan liability | |||||||||
| Accrued interest payable and other liabilities | |||||||||
| Total liabilities | |||||||||
| Stockholders' Equity | |||||||||
| Common stock - $.01 par value, 14,000,000 shares authorized, 541,434 shares issued and outstanding at June 30, 2026 and March 31, 2026 | |||||||||
| Additional paid in capital | |||||||||
| Unallocated common stock of ESOP | |||||||||
| Retained earnings | |||||||||
| Treasury stock - 21,000 shares | |||||||||
| Deferred compensation plan - Rabbi Trust - 21,000 shares | |||||||||
| Accumulated other comprehensive loss | |||||||||
| Total stockholders' equity | |||||||||
| Total liabilities and stockholders' equity |
Loading...
